June 2020 Clinical Watch Newsletter

July 8, 2020

In this issue of Clinical Watch, we discuss nitrosamine impurities found in widely used medications and suggest prior authorization criteria for a new treatment for heavy menstrual bleeding due to uterine fibroids. Lastly, we review claims data to identify the most frequently used contraceptive formulations.

For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Article
How Major Healthcare Payers are Automating Open Enrollment
How Major Healthcare Payers are Automating Open Enrollment

Advanced digital capabilities take the stress out of the busiest time of the year

Next Flipbook
Healthcare Payer Operations – Services PEAK Matrix® Assessment 2020
Healthcare Payer Operations – Services PEAK Matrix® Assessment 2020